Crossmark

Dapagliflozin ameliorates Alzheimer’s disease in rats via stimulating the protective arm of renin angiotensin system and suppressing neuroinflammation

Crossref DOI link: https://doi.org/10.1007/s10787-026-02345-9

Published Online: 2026-07-24

Published Print: 2026-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Awwad, Zeinab M. https://orcid.org/0000-0002-8073-8122
Funding

Funding for this research was provided by:

Pharos University
License Information

Text and Data Mining valid from 2026-07-24

Version of Record valid from 2026-07-24
More Information

Article History

Received: 30 May 2026

Accepted: 12 July 2026

First Online: 24 July 2026

Declarations

Conflict of interest: The authors declare no conflict of interests.

Document is current

Any future updates will be listed below